🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In this prospective study, 68Ga-PSMA integrated PET/MR imaging was applied ...
Status
Unknown
Location
China, Hubei Province
Start Date
2021-08-16
Trial ID
NCT05006326
In advanced metastatic castration resistant prostate cancer (mCRPC) progres...
Status
Recruiting
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2024-08-01
Trial ID
NCT06216249
This phase I trial compares the effect of lutetium Lu 177 (177\^Lu)-prostat...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2026-03-06
Trial ID
NCT07219147
This prospective phase II study assesses the accuracy of second generation ...
Status
Completed
Location
University of Alberta
Start Date
2022-02-10
Trial ID
NCT05141760
Treatments Being Tested
This phase III study provides access to 68Ga-PSMA-11 positron emission tomo...
Status
Completed
Location
Mayo Clinic in Rochester
Start Date
2022-05-09
Trial ID
NCT05547386
Treatments Being Tested
An improved diagnosis of bone metastases in prostate cancer patients can ha...
Status
Unknown
Location
Department of Radioogy/Department of Nuclear Medicine
Start Date
2014-04
Trial ID
NCT03134261
Treatments Being Tested
Parathyroid glands are in the neck and produce a substance called parathorm...
Status
Terminated
Location
Emory Saint Joseph's Hospital
Start Date
2022-03-31
Trial ID
NCT05299632
Treatments Being Tested
Obtain PSMA-PET imaging preoperatively and calculate performance for predic...
Status
Completed
Location
Indiana University Health University Hospital
Start Date
2021-06-11
Trial ID
NCT04936334
Treatments Being Tested
This phase II trial studies how to improve the usage of Lu 177 vipivotide t...
Status
Suspended
Location
Mayo Clinic in Rochester
Start Date
2024-05-03
Trial ID
NCT06200103
Patients with metastatic prostate cancer will undergo two protocol 68Ga-PET...
Status
Completed
Location
Weill Cornell Medicine
Start Date
2020-12-09
Trial ID
NCT04685811
Treatments Being Tested